Clinical Trial Update: Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

View source ↗

Summary

The clinical trial evaluating Levemir for treatment of type 1 and type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED